Innophore is a TechBio company advancing protein and drug discovery through AI-augmented structural biology. Our proprietary Catalophore™ technology analyzes the shape and chemistry of protein binding sites using multidimensional point clouds, revealing function, binding behavior, and druggable opportunities with greater speed and precision than conventional methods. From identifying targets across entire proteomes to repurposing existing drugs, our platform empowers pharmaceutical R&D with faster, smarter decision-making.